Chris Fry, PhD, is a Senior Director of Epigenetics, Assays, and Workflow Solutions at Cell Signaling Technology. He is an epigenetics scientist trained at the University of Wisconsin and UMass Medical Center. At CST, he is helping to develop and manage the epigenetics product portfolio with a specific interest in developing antibodies and antibody-based tools to investigate epigenetic mechanisms in disease.
